Imunon, Inc.
IMNN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $12,573 | $7,073 | $11,089 | $3,370 |
| - Cash | $5,873 | $5,839 | $11,493 | $19,586 |
| + Debt | $1,139 | $1,625 | $6,266 | $6,634 |
| Enterprise Value | $7,839 | $2,860 | $5,863 | -$9,582 |
| Revenue | $0 | $0 | $500 | $500 |
| % Growth | – | -100% | 0% | – |
| Gross Profit | $0 | $0 | $500 | $500 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$17,902 | -$19,878 | -$31,705 | -$20,880 |
| % Margin | – | – | -6,341% | -4,176% |
| Net Income | -$18,620 | -$19,515 | -$35,898 | -$20,769 |
| % Margin | – | – | -7,179.6% | -4,153.9% |
| EPS Diluted | -21.104 | -28.141 | -65.552 | -748.772 |
| % Growth | 25% | 57.1% | 91.2% | – |
| Operating Cash Flow | -$18,855 | -$19,022 | -$23,097 | -$16,224 |
| Capital Expenditures | -$30 | -$452 | -$268 | -$312 |
| Free Cash Flow | -$18,885 | -$19,474 | -$23,365 | -$16,535 |